Skip to main content
. 2021 May 7;9(6):850–859. doi: 10.14218/JCTH.2021.00046

Fig. 1. Cumulative incidence rates of long-term clinical outcome according to virological response.

Fig. 1

(A) End-stage liver disease. (B) Decompensated cirrhosis. (C) HCC. (D) End-stage liver disease after PS matching. (E) Decompensated cirrhosis after PS matching. (F) HCC after PS matching. LLV, low-level viremia; MVR, maintained virological response; HCC, hepatocellular carcinoma; PS matching, propensity score matching.